Status:
COMPLETED
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
Lead Sponsor:
SCRI Development Innovations, LLC
Collaborating Sponsors:
Biotheranostics, Inc.
Conditions:
Unknown Primary Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay result...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with RT-PCR testing completed since commercialization of the RT-PCR assay in 2007.
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00876408
Start Date
May 1 2009
End Date
November 1 2010
Last Update
December 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tennessee Oncology, PLLC
Nashville, Tennessee, United States, 37023